Natrix Separations Raises Second Round

Natrix Separations Inc., a Canadian maker of membrane-based disposable chromatography products, has raised C$19 million in Series B funding. D.E. Shaw Venture Capital led the round, and was joined by the Canadian Medical Discoveries Fund (managed by JovInvestment Management) and BDC Venture Capital.



Natrix Separations Inc., a privately held company that develops and manufactures high performance, membrane-based disposable chromatography products, announced today that it has closed a Series B financing totaling $19 Million. The round was led by D.E. Shaw Venture Capital of Cupertino, CA, and included existing investors the Canadian Medical Discoveries Fund, managed by JovInvestment Management Inc., part of Jovian Capital Corporation, and the venture capital arm of the Business Development Bank of Canada, BDC Venture Capital. The proceeds of this raise are being used to complete the construction of Natrix's ISO 9001 compliant commercial manufacturing facility, and to support the commercialization of Natrix's diverse portfolio of separation products based on the company's patented adsept